Characterization of p53 gene mutations in esophageal squamous cell carcinoma cell lines: Increased frequency and different spectrum of mutations from primary tumors

International Journal of Cancer

Volumn 65, Issue 3, 1996, Pages 372-376

  Tanaka, Hisashi ^a,b   Shibagaki, Ichio ^b   Shimada, Yutaka ^b   Wagata, Takashi ^b   Imamura, Masayuki ^b   Ishizaki, Kanji ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030046132     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960126)65:3<372::AID-IJC16>3.0.CO;2-C     Document Type: Article

References (21)

1. BAKER, S., MARCOWITZ, S., FEARON, E., WILSON, J. and VOGELSTEIN, B., Suppression of human colorectal carcinoma cell growth by wild type p53. Science, 249, 912-915 (1990).
2. BENNETT, W.P., HOLLSTEIN, M.C., HE, A., ZHU, S.M., RESAU, J.H., TRUMP, B.F., METCALF, R.A., WELSH, J.A., MIDGLEY, C., LANE, D.P. and HARRIS, C.C , Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene, 6, 1779-1784 (1991).
3. CHIBA, I. and 13 OTHERS, Mutations in the p53 gene are frequent in primary, resected non small cell lung cancer. Oncogene, 5, 1603-1610 (1990).
4. FAN. E., LEVIN, D.B., GLIDECKMAN, B.W. and LOGAN, D.M., Limitation in the use of SSCP analysis. Mutation Res., 288, 85-92 (1993).
5. GAIDANO, G., BALLELINI, P., GONG, J.Z., INGHIRAMI, G., NERI, A., NEWCOMB, E.W., MAGRATO, I.T., KNOWLES, D.M. and DALLAFAVERA, R., p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocvtic leukemia. Proc. nat. Acad. Sci. (Wash.), 88, 5413-5417 (1991).
6. GAO, H., WANG, L.D., ZHOU, Q., HONG, J.Y., HUANG, T.Y. and YANG, C.S. p53 tumor suppressor gene mutation in early esopbageal precancerous lesions and carcinoma among high risk population in Henan, China. Cancer Res., 54, 4342-4346 (1994).
7. GREENBLATT, M.S., BENETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
8. HOLLSTEIN, M., PERI, L., MANDARD, A.M., WELSH, J.A., MONTESANO, R., METCALF, R.A., BAK, M. and HARRIS. C.C., Genetic analysis of human esophageal tumors from high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res. 51, 4102-4106 (1991).
9. HOLLSTEIN, M., RICE, K., GREENBLATT, M.S., SOUSSI, T., FUCHUS, R., SORLIE, T., HOVIG, E., SMITH-SORENSEN, B., MONTESANO, R. and HARRIS. C.C., Database of p53 gene somatic mutation in human tumors and cell lines. Nucleic Acids Res., 22, 3551-3555 (1994).
10. HORIO, Y., SUZUKI, H., UEDA, R., KOSHIGAWA, T., SUGIURA, T., ARIYOSHI, Y., SHIMOKATA, K., TAKAHASHI, T. and TAKAHASHI, T., Predominantly tumor limited expression of mutant allele in a Japanese family carrying a germline mutation. Oncogene, 9, 1231-1235 (1994).
11. KATO, M.V., ISHIZAKI, K., TOGUCHIDA, J. and SASAKI. M.S., Mutations in the retinoblastoma gene and their expression in somatic and tumor cells of patient with hereditary retinoblastoma. Hum. Mutation, 3, 44-51 (1994).
12. ORITA, M., SUZUKI, Y., SEKIYA, T. and HAYASHI, K., Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction. Genomics, 5, 874-879 (1989).
13. SAKAI, E., RIKIMARU, K., UEDA, M., MATSUMOTO, Y., ISHII, N., ENOMOTO, S., YAMAMOTO, H. and TSUCHIDA. N., The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous cell carcinoma. Int. J. Cancer, 52, 867-872 (1992).
14. SHIBAGAKI. I., TANAKA, H., SHIMADA, Y., WAGATA, T., IKENAGA, M., IMAMURA, M. and ISHIZAKI, K., p53 mutation, murine double minute 2. amplification and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Clin. Cancer Res., 1, 769-773 (1995).
15. SHIMADA, Y. and IMAMURA, M., Prognostic significance of cell culture in carcinoma of esophagus. Brit. J. Surg., 80, 605-607 (1993).
16. SHIMADA, Y., IMAMURA, M., WAGATA, T. and TOBE, T., Characterization of 21 newly established esophageal cancer cell lines. Cancer, 69, 277-284 (1992).
17. TAKAHASHI, T., D'AMICO, D., CHIBA, I., BUCHRAGEN, D.L. and MINNA, J., Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. J. clin. Invest, 86, 363-369 (1990).
18. TOGUCHIDA, J. and 12 OTHERS, Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res., 52, 6194-6199 (1992).
19. WAGATA, T., SHIBAGAKI, I., IMAMURA, M., SHIMADA, Y., TOGUCHIDA, J., YANDELL, D.W., IKENAGA, M., TOBE, T. and ISHZAKI, K., Loss of 17p, mutation of p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res., 53, 846- 850 (1993).
20. WANG, L.D., HONG, J.Y., QIU, S.L., GAO, H. and YANG, C.S., Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res , 53, 1783-1787 (1993).
21. WRIGHT, P.A., LEMOINE, N.R., GORETZKI, P.E., WILLIE, F.S., BOND, J., HUGHES, C., ROHER, H.D., WILLIAMS, E.D. and WYNFORDTHOMAS, D., Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumors. Oncogene, 6, 1693-1697 (1991).